Actemra SC — Medical Mutual

Initial criteria

• Patient has tried one conventional synthetic DMARD for at least 3 months OR patient has had a 3-month trial of at least one biologic other than tocilizumab; AND
• Medication is prescribed by or in consultation with a rheumatologist

Reauthorization criteria

• Patient has been established on therapy for at least 6 months; AND
• Patient experienced a beneficial clinical response assessed by objective measures OR patient experienced an improvement in at least one symptom compared with baseline

Approval duration

initial: 6 months; reauth: 1 year